HOSPITALIZATION AND MORTALITY IN MEDICARE HEART FAILURE PATIENTS

被引：0
|
作者：
Hunt, P. R. [1 ]
Veath, B. K. [2 ]
Tsintzos, S. [3 ]
Burton, M. L. [3 ]
Mollenkopf, S. A. [3 ]
机构：
[1] United BioSource Corp Inc, Lexington, MA USA
[2] Medtron Int Ltd, Mounds View, MN USA
[3] Medtronic Inc, Mounds View, MN USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1440
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A278 / A278
页数：1
相关论文
共 50 条
  • [41] Predictors of mortality after hospitalization for decompensated heart failure
    Aronson, D
    Horton, DP
    Burger, AJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 142A - 142A
  • [42] Evaluation of mortality and readmissions following hospitalization with heart failure
    Swindle, Jason P.
    Chan, Wing W.
    Johnson, Katherine Waltman
    Becker, Laura
    Blauer-Peterson, Cori
    Altan, Aylin
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (10) : 1745 - 1755
  • [43] Heart failure and hospitalization: are they the same patients?
    Casado, JMR
    REVISTA CLINICA ESPANOLA, 2006, 206 (01): : 60 - 60
  • [44] Mortality risk of patients with heart failure with mid-range ejection fraction following a hospitalization with acute heart failure
    Cardells Beltran, I. Ingrid
    Santas Olmeda, E.
    Paya Chaume, A.
    Heredia Cambra, R.
    Escribano Alarcon, D.
    Minana Escriva, G.
    Bayes Genis, A.
    Lupon Roses, J.
    Sanchis Fores, J.
    Chorro Gasco, F. J.
    Nunez Villota, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 212 - 212
  • [45] Use of Traditional Heart Failure Medications in Patients With Cardiac Amyloidosis and Heart Failure is Safe but Does Not Improve Mortality or Hospitalization
    Yan, Crystal L.
    Gallo, Ryan A.
    Vasquez, Moises
    Rodriguez, Beatriz Rivera
    Trujillo, Luis
    Rivera, Nina
    Hoffman, James
    CIRCULATION, 2023, 148
  • [46] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Taher M. Mandviwala
    Sukhdeep S. Basra
    Umair Khalid
    June K. Pickett
    Ryle Przybylowicz
    Tina Shah
    Vijay Nambi
    Salim S. Virani
    Anita Deswal
    International Journal of Obesity, 2020, 44 : 1561 - 1567
  • [47] For patients with heart failure with preserved ejection fraction, is empagliflozine effective and safe for preventing cardiovascular mortality and heart failure hospitalization?
    Lanthier, L.
    Dussault, C.
    Plourde, M-E
    Cauchon, M.
    REVUE DE MEDECINE INTERNE, 2021, 42 (11): : 814 - 815
  • [48] Preemptive Versus Urgent Heart Failure Hospitalization as a Surrogate for Mortality Risk in Heart Failure
    Kapelios, Chris J.
    Lund, Lars H.
    CIRCULATION, 2024, 149 (14) : 1062 - 1064
  • [49] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Mandviwala, Taher M.
    Basra, Sukhdeep S.
    Khalid, Umair
    Pickett, June K.
    Przybylowicz, Ryle
    Shah, Tina
    Nambi, Vijay
    Virani, Salim S.
    Deswal, Anita
    INTERNATIONAL JOURNAL OF OBESITY, 2020, 44 (07) : 1561 - 1567
  • [50] Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension
    Navaneethan, Sankar D.
    Walther, Carl P.
    Gregg, L. Parker
    Bansal, Shweta
    Winkelmayer, Wolfgang C.
    Nambi, Vijay
    Niu, Jingbo
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (05) : 700 - +
12345